SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Synsorb Biotech

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Fred J Bealle who wrote (16)2/27/1997 1:08:00 PM
From: Fred J Bealle   of 32
 
To all; Altamira Special Growth has 136 or so stocks in small cap range, in their fund. Of the top 10 holdings (25%) one is Synsorb, at 2 or 3 %. The fund manager is very bullish on this stock, and in a seminar (Toronto Feb 25) described its lifesaving properties.
To me that was a good sign, and I picked up some more shares at 10.75. It looks to me like Synsorb isnt going to drop down much, unless somebody does something stupid.
In a general market crash, SYB would be a good stock to accumulate.
If, however, Syb got sued, I would perhaps review my holdings.

News today: Syb is moving into a production phase? I would conclude that they are going to produce new product fairly soon, so expect to sell it, which implies a non-milestone revenue increase! Idle speculation of the ill-informed. (me)
Synsorb Biotech Inc SYB
Shares issued 16,084,520 Feb 26 close $10.70
Thu 27 Feb 97 News Release
Mr Brad Thompson reports
Dr R.M. Ratcliffe has been appointed vice-president, chemical development
and manufacturing.
(c) Copyright 1997 Canjex Publishing Ltd. canada-stockwatch.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext